Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Journal of Autism and Developmental Disorders
|
September 5, 2018
The Severe End of the Spectrum: Insights and Opportunities from the Autism Inpatient Collection (AIC)
Matthew Siegel
Child and Adolescent Psychiatric Clinics of North America
|
October 9, 2012
Psychopharmacology of autism spectrum disorder: evidence and practice
Matthew Siegel
International Review of Psychiatry (Abingdon, England)
|
March 15, 2018
Psychiatric hospital treatment of youth with autism spectrum disorder in the United States: needs, outcomes, and policy
Kelly McGuire, Matthew Siegel
Pharmacology & Therapeutics
|
June 22, 2007
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel, Chaitan Khosla
Journal of Autism and Developmental Disorders
|
November 10, 2011
Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice
Matthew Siegel, Amy A Beaulieu
Child and Adolescent Psychiatric Clinics of North America
|
November 16, 2013
Psychiatric hospital treatment of children with autism and serious behavioral disturbance
Matthew Siegel, Robin L Gabriels
Child and Adolescent Psychiatric Clinics of North America
|
November 16, 2013
Autism and developmental disorders: management of serious behavioral disturbance
Matthew Siegel, Bryan H King
Pediatrics in Review
|
July 3, 2008
Fears and phobias
Jacques Benun, Carol Lewis, Matthew Siegel
Bioorganic & Medicinal Chemistry
|
June 26, 2007
Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2
Matthew Siegel, Jiang Xia, Chaitan Khosla
Pediatrics
|
August 5, 2015
Pediatric Professional Medical Associations and Industry Guideline Compliance
Matthew Siegel, Amy Stedman, Kahsi A Smith
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Journal of Autism and Developmental Disorders
|
September 5, 2018
The Severe End of the Spectrum: Insights and Opportunities from the Autism Inpatient Collection (AIC)
Matthew Siegel
Child and Adolescent Psychiatric Clinics of North America
|
October 9, 2012
Psychopharmacology of autism spectrum disorder: evidence and practice
Matthew Siegel
International Review of Psychiatry (Abingdon, England)
|
March 15, 2018
Psychiatric hospital treatment of youth with autism spectrum disorder in the United States: needs, outcomes, and policy
Kelly McGuire, Matthew Siegel
Pharmacology & Therapeutics
|
June 22, 2007
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel, Chaitan Khosla
Journal of Autism and Developmental Disorders
|
November 10, 2011
Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice
Matthew Siegel, Amy A Beaulieu
Child and Adolescent Psychiatric Clinics of North America
|
November 16, 2013
Psychiatric hospital treatment of children with autism and serious behavioral disturbance
Matthew Siegel, Robin L Gabriels
Child and Adolescent Psychiatric Clinics of North America
|
November 16, 2013
Autism and developmental disorders: management of serious behavioral disturbance
Matthew Siegel, Bryan H King
Pediatrics in Review
|
July 3, 2008
Fears and phobias
Jacques Benun, Carol Lewis, Matthew Siegel
Bioorganic & Medicinal Chemistry
|
June 26, 2007
Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2
Matthew Siegel, Jiang Xia, Chaitan Khosla
Pediatrics
|
August 5, 2015
Pediatric Professional Medical Associations and Industry Guideline Compliance
Matthew Siegel, Amy Stedman, Kahsi A Smith
Page
of 9